{"id":"NCT03183128","sponsor":"Seres Therapeutics, Inc.","briefTitle":"ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection","officialTitle":"A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-07-10","primaryCompletion":"2020-07-03","completion":"2020-09-29","firstPosted":"2017-06-09","resultsPosted":"2023-04-27","lastUpdate":"2023-04-27"},"enrollment":182,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Clostridium Difficile Infection"],"interventions":[{"type":"BIOLOGICAL","name":"SER-109","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"SER-109","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo once daily for 3 consecutive days in Treatment Group II. The purpose of this study is to demonstrate the superiority of SER-109 vs placebo to reduce recurrence of CDI as determined by a toxin assay in adults up to 8 weeks after initiation of treatment.","primaryOutcome":{"measure":"Recurrence of CDI up to 8 Weeks","timeFrame":"Up to Week 8","effectByArm":[{"arm":"SER-109","deltaMin":11,"sd":null},{"arm":"Placebo","deltaMin":37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":56,"countries":["United States","Canada"]},"refs":{"pmids":["38941068","36716031","35045228"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":90},"commonTop":["Flatulence","Fatigue","Abdominal pain","Abdominal distension","Decreased appetite"]}}